Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMM2 | O15305 | 1/20 | 0.37 |
| ▸ | MPI | P34949 | 1/20 | 0.37 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17299412 | 0.91 | PMM2 (0.39) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL18687749 | 0.90 | ERBB2 (0.32) | PMM2MPIPHOSPHO1TP53MAPT | |
| SCHEMBL19961680 | 0.89 | PMM2 (0.38) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL17427709 | 0.89 | PMM2 (0.39) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL18960866 | 0.89 | PMM2 (0.39) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL17427577 | 0.88 | PMM2 (0.40) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL17427612 | 0.87 | PMM2 (0.41) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL10014562 | 0.87 | PMM2 (0.41) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL10014499 | 0.85 | PMM2 (0.40) | PMM2MPIPHOSPHO1TP53HPGD | |
| SCHEMBL18748634 | 0.85 | PMM2 (0.36) | PMM2MPIPHOSPHO1TP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840457-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-11-17 | — | — | US | disclosed |
| WO-2017052099-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2017-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10840457-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OR10J3, OCIAD1 | PMM2 2716/4885MPI 3487/4885PHOSPHO1 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.